Palak Shah, MD, MS is Medical Director of the Mechanical Circulatory Support (MCS) and Heart Failure Research programs at the Inova Heart and Vascular Institute and is an Associate Professor of Medicine at George Washington University (adj). His training encompassed multiple institutions: Georgetown University, George Washington University, and the University of Michigan. During cardiovascular medicine fellowship, he was elected to the Alpha Omega Alpha Honor’s society and to solidify his research training, obtained a Masters in Clinical and Translational Research. His research is focused on the use of clinical risk prediction models, machine learning and biomarkers to improve outcomes of patients with advanced heart failure. In his translational lab, Dr. Shah’s team performs protein and genomic based assays to develop circulating biomarkers with excellent translational capability. This led to him being co-awarded the 2021 James T. Willerson Award for top clinical science paper in Circulation. He has also served as a principal investigator or on the steering committee for multiple multicenter clinical trials. He was former Chair for the MCS Steering Committee of the International Society for Heart and Lung Transplantation (ISHLT). By better understanding and characterizing patients with advanced heart failure, mechanical circulatory support, or cardiac transplantation, his goals are to identify novel clinical management strategies as well as inform the development of newer therapeutics that improve long-term outcomes for patients living with heart failure.